Osteonecrosis of the jaw (ONJ) is a serious complication for physicians prescribing bone resorption inhibitors to patients with osteoporosis. A session at the recent French Congress of Rheumatology ...

Older women who received denosumab (Prolia, Amgen) for up to 10 years for osteoporosis had a low risk of osteonecrosis of the jaw (ONJ), although the risk was higher — albeit still quite small — if ...

A troubling jaw disease that may be related to the use of some of the most commonly used osteoporosis medications has been the subject of many news stories and law firm commercials lately. The disease ...

Please provide your email address to receive an email when new articles are posted on . Bisphosphonate-associated osteonecrosis of the jaw presents in patients as exposed, non-healing bone in the oral ...

Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing osteonecrosis of the jaw (ONJ) in patients who take ...

BOSTON -- Osteonecrosis of the jaw (ONJ) is rare in patients taking the antiresorptive drug denosumab (Prolia), even when invasive dental procedures are performed, according to up to 8 years of data ...

ONJ is a clinical entity with many possible etiologies; historically identified risk factors include corticosteroids, chemotherapy, radiotherapy, trauma, infection, and cancer. With emerging concern ...

A Montana jury yesterday awarded $3.2 million to a woman who sued the makers of the bone-strengthening drug Zometa. The verdict could set a precedent for hundreds of similar cases pending against the ...

The use of antiresorptive drugs for tumor-related disorders and oral, but not injectable, corticosteroids were associated with an increased risk for osteonecrosis of the jaw among patients with ...

Bisphosphonates are popular bone-targeting drugs. Older people take them to prevent and treat osteoporosis. Breast cancer patients, particularly those with metastatic disease, take them to prevent and ...

A troubling jaw disease that may be related to the use of some of the most commonly used osteoporosis medications has been the subject of many news stories and law firm commercials lately. The disease ...